Study uncovers hidden risks in normal kidney function tests

Researchers at Karolinska Institutet have found that even kidney test results within the normal range can signal future chronic kidney disease if they are low for a person's age. The study, based on data from over 1.1 million adults in Stockholm, introduces reference charts and an online tool to help doctors identify at-risk patients earlier. This could prevent serious damage, as kidney disease often goes undetected until half of kidney function is lost.

Chronic kidney disease affects 10 to 15 percent of adults worldwide and is projected to become one of the top five causes of years of life lost by 2040. A major issue is late diagnosis, with many patients only identified after more than half their kidney function has declined, limiting treatment options. To address this, scientists from Karolinska Institutet analyzed nearly seven million estimated glomerular filtration rate (eGFR) tests from 2006 to 2021, covering about 80 percent of Stockholm residents aged 40 to 100.

The team created population-based reference charts for eGFR, comparing an individual's results to age- and sex-matched norms rather than fixed cutoffs. This method, inspired by pediatric growth charts, aims to spot subtle risks sooner. "We were inspired by the growth and weight charts used in pediatrics, which intuitively help clinicians identify children at risk of obesity or undergrowth," said Yuanhang Yang, the study's first author and a postdoctoral researcher at Karolinska Institutet.

Key findings link lower eGFR percentiles to worse outcomes. People below the 25th percentile faced higher risks of kidney failure needing dialysis or transplantation. A U-shaped pattern emerged for mortality, with both very low and very high percentiles associated with increased death risk. Yet, clinical practice lags: only one in four individuals with eGFR above 60 ml/min/1.73 m² but below the 25th percentile received urinary albumin testing, crucial for early detection.

For instance, a 55-year-old woman with an eGFR of 80 might seem fine, but it places her in the 10th percentile for her age, tripling her future dialysis risk. "This signals an opportunity to act earlier," noted Juan Jesús Carrero, a professor at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet.

The researchers developed a free online calculator by PhD student Antoine Creon to integrate these charts into routine care. Funded by entities like the Swedish Research Council and part of the SCREAM project, the study reports no conflicts of interest. Published in Kidney International, it underscores the need for age-adjusted evaluations to enable prevention.

Связанные статьи

Global map and diverse people illustrating the rising prevalence of chronic kidney disease worldwide, with medical elements highlighting the need for early detection.
Изображение, созданное ИИ

Chronic kidney disease now affects 788 million people worldwide, study finds

Сообщено ИИ Изображение, созданное ИИ Проверено фактами

A Lancet analysis estimates that nearly 800 million adults were living with chronic kidney disease in 2023—up from 378 million in 1990—with the illness now ranking ninth among global causes of death. Researchers urge earlier detection and wider access to proven treatments.

On World Kidney Day, March 12, knowledge about kidney disease is spread globally. About one in ten Swedes has impaired kidney function without symptoms, posing major health risks if detected late. The Njurföreningen Gävle-Dala urges Region Dalarna to implement routine testing at primary care centers to catch the disease early.

Сообщено ИИ Проверено фактами

A large study published in Neurology finds that impaired kidney function is linked to higher levels of Alzheimer’s biomarkers in the blood, without increasing overall dementia risk. However, among people who already have elevated biomarker levels, poor kidney health may hasten when dementia symptoms appear, underscoring the need to factor kidney function into interpretation of Alzheimer’s blood tests.

Researchers have developed a deep learning model that estimates chronic stress burden by measuring adrenal gland volume on standard CT scans, introducing what they describe as the first imaging-based biomarker for chronic stress. The metric, called the Adrenal Volume Index, is linked to cortisol exposure, perceived stress, overall physiological stress load and long-term cardiovascular risk, according to findings to be presented at the Radiological Society of North America's annual meeting.

Сообщено ИИ Проверено фактами

A Mount Sinai–led study finds that commonly used heart-attack risk calculators and symptom-based screening fail to identify nearly half of people who will soon experience a first heart attack. The brief report, published November 21 in JACC: Advances, underscores limitations in current prevention strategies and argues for earlier imaging to detect silent plaque.

A new Karolinska Institutet study finds that children with moderate obesity face higher risks of type 2 diabetes, high blood pressure, and lipid disorders in adulthood, even without apparent risk markers. Researchers urge treatment for all such children.

Сообщено ИИ Проверено фактами

A proposed update to how obesity is defined—combining body mass index with measures of abdominal fat—would raise the share of U.S. adults classified as having obesity from about 43% to roughly 69%, according to a Mass General Brigham analysis of more than 300,000 participants in the National Institutes of Health’s All of Us Research Program.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить